PNPLA3 and metabolic dysfunction-associated steatotic liver disease: As shown in Fig. 7A,B, there was a large variation in hepatic PNPLA3 mRNA expression level, and it was positively correlated with hepatic triglyceride and DAG content, supporting the hypothesis that PNPLA3 plays a lipogenic role in humans with NAFLD.